SLC2A10 Gene Arterial Tortuosity Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين SLC2A10 لمتلازمة تعرج الشرايين في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

الملخص التنفيذي: نقدم تحليل جين SLC2A10 بتقنية التسلسل الجيني المتقدم (NGS) بدقة تشخيصية تصل إلى 99.9% عبر معالجة معتمدة من ISO. خدمة سحب منزلي على مستوى المستشفى، وإرشاد سريري هاتفي بعد النتيجة، والتحقق المباشر من التأمين عبر واتساب. جميع الخدمات متوافقة مع أحكام المرسوم بقانون اتحادي رقم 41 لسنة 2024 (المادة 87) وقانون حماية البيانات الشخصية (PDPL).

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
Premium Logistics: Hospital-Grade Home Collection via ISO Certified Cold-Chain (8 AM – 11 PM) & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

This next-generation sequencing (NGS) test analyzes the SLC2A10 gene for pathogenic variants causing Arterial Tortuosity Syndrome (ATS), a rare autosomal recessive connective tissue disorder characterized by elongated, tortuous arteries leading to stenosis, aneurysms, and dissection. التحليل يكشف الطفرات المسببة لمرض تعرج الشرايين الوراثي ويُستخدم للتشخيص الدقيق وتوجيه العلاج.

Feature	Our SLC2A10 NGS Test	Conventional Sanger Sequencing
Methodology	Full gene NGS (Illumina) with VUS resolution & copy number analysis	Targeted Sanger sequencing of exonic regions only
Coverage	100% exonic & intron-exon boundaries, depth >100x	~85–90% coverage; may miss deep intronic variants
Turnaround Time	3–4 Weeks	4–6 Weeks
Clinical Interpretation	Included genetic counseling session & comprehensive report	Basic report; counseling often separate
Regulatory Compliance	Full DHA/MOHAP, ISO 9001:2015, UAE PDPL	May not include UAE-specific data privacy guarantees

Physician Insight & Safety Protocol

“As a clinical pathologist, I understand that genetic testing for rare disorders like Arterial Tortuosity Syndrome can be daunting. This test provides definitive molecular confirmation, but results must be interpreted within the context of your family history and clinical findings; a negative result does not exclude all genetic risks. Please consult your doctor for comprehensive care.” – Dr. PRABHAKAR REDDY (DHA License: 61713011)

⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic results do not replace ongoing medical management.

Patient Safety & Exclusion Criteria

Test is not recommended as a standalone screening tool for newborns or children without clinical suspicion; pediatric cases require genetic counseling per CDS Law 2026 (Minors).
Pregnancy is not a contraindication, but pre-test counseling is mandatory due to potential implications for family planning.
Patients with active bleeding disorders must inform the phlebotomist before blood draw.

🚨 Emergency Red Flags After Test (Seek Immediate Care):

Sudden severe chest or back pain (possible aortic aneurysm/dissection).
Sudden severe headache, vision changes, or neurological deficits (cerebral artery involvement).
Acute limb pain, pallor, or absent pulses (peripheral artery thrombosis).

Frequently Asked Questions (Bilingual)

1. What is the SLC2A10 gene test used for?

Snippet: The SLC2A10 gene test definitively diagnoses Arterial Tortuosity Syndrome by detecting pathogenic mutations causing arterial elongation and vascular complications.

This test is ordered by a general physician, medical researcher, or laboratory scientist when a patient presents with tortuous arteries, early-onset hypertension, or a family history of sudden vascular events. It confirms the molecular basis of the disease, guides surveillance (e.g., regular vascular imaging) and helps identify at-risk relatives.

سؤال: ما فائدة تحليل جين SLC2A10؟

الجواب: يُستخدم هذا التحليل لتأكيد تشخيص متلازمة تعرج الشرايين الوراثية بدقة تصل إلى 99.9%، مما يُتيح مراقبة الأوعية الدموية واتخاذ التدابير الوقائية.

2. How accurate is this Genetic Test in detecting SLC2A10 mutations?

Snippet: Our NGS achieves 99.9% diagnostic sensitivity for SLC2A10 variants with full gene coverage and orthogonal validation using ISO 9001:2015 protocols.

The technology sequences the entire coding region and splice junctions at high depth, detecting single nucleotide variants, small indels, and copy number changes. All pathogenic findings are confirmed by an independent method before reporting, ensuring clinical-grade accuracy.

سؤال: ما مدى دقة هذا التحليل الجيني؟

الجواب: تبلغ الحساسية التشخيصية 99.9% بفضل التغطية الكاملة للجين والتحقق الإضافي، مما يجعله من أدق الفحوصات المتاحة عالميًا.

3. Is home sample collection available in Dubai and Abu Dhabi?

Snippet: Yes, our ISO-certified phlebotomy team provides hospital-grade home blood collection across all UAE emirates from 8 AM to 11 PM daily.

Whole blood, extracted DNA, or a single drop on an FTA card can be collected in the comfort of your home. The specimen is transported in temperature‑controlled, validated cold‑chain containers directly to our DHA‑licensed facility. Appointments are scheduled via WhatsApp at +971 54 548 8731.

سؤال: هل تتوفر خدمة السحب المنزلي في دبي وأبوظبي؟

الجواب: نعم، نوفر خدمة سحب الدم منزليًا وفق معايير المستشفيات من الساعة 8 صباحًا حتى 11 مساءً في جميع إمارات الدولة، مع نقل مبرد معتمد.

Regulatory Compliance: This service adheres to Federal Decree-Law No. 41 of 2024 (Art. 87), UAE PDPL, CDS Law 2026 for minors, and is performed under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) at a DHA-licensed facility (License: 9834453).

دعم ثنائي اللغة متاح